Stock Report

All about this stock under one free report Last Updated: 29-Aug-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Rubius Therapeutics (RUBY) Key Ratios

Stock Card factsheet share-fund-plan-icon

$0.06

up-down-arrow $0.04 (171.43%)

As on 29-Dec-2023 15:49EDT

Market cap

info icon

$5 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.3

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 99.79 99.78 19.81 1.55 -210.35
Net Profit 55.57 24.97 -18.93 -17.09 -227.21
EPS 55.54 25.29 -15.97 -9.05 8.22
Book Value -- -- -91.57 -63.49 --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-22Dec-21Dec-20
EBIT-Margin info ----------
Net Margin info -4,888.51-3,664.15---4,193.29-5,583.74
Return on equity info -144.65-106.62-238.11-117.89-77.95
Return on Capital info -89.93-70.04-149.68-68.61-51.49
Return on Assets info -82.31-62.81-135.37-63.38-48.18
Debt to Equity (x) info ----0.070.630.82

Profitability

View Detailed Peer Comparison

ROCE

-149.68

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
-149.68
-68.61
-51.49
-38.46
-41.97
Peer Median
--
--
--
--
--
ROE

-238.11

--

Profit after tax / Average Net worth * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
-238.11
-117.89
-77.95
-48.10
-51.07
Peer Median
--
--
--
--
--
ROA

-135.37

--

Profit after tax / Average Total assets * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
-135.37
-63.38
-48.18
-36.72
-30.40
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
--
-4,193.29
-5,583.74
-1,837.43
-3,042.12
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

EBIT Growth

8.31

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
8.31
-16.92
1.86
-85.03
-114.40
Peer Median
--
--
--
--
--
Net Profit Growth

-22.26

--

Year on year growth in profit after tax

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
-22.26
-16.53
-0.98
-79.90
-103.42
Peer Median
--
--
--
--
--
EPS Growth

-0.22

--

Year on year growth in earnings per share

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
-0.22
-0.05
0.01
-0.73
0.77
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.07

--

Total debt / Net worth

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
0.07
0.63
0.82
0.35
0.18
Peer Median
--
--
--
--
--
Short term debt to equity ratio

0.07

--

(Short term borrowings / Net worth)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
0.07
0.05
0.06
0.04
0.01
Peer Median
--
--
--
--
--
Current Ratio

2.54

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
2.54
6.63
6.52
8.57
20.72
Peer Median
--
--
--
--
--
Interest Coverage

-46.19

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
-46.19
-30.25
-39.77
-65.48
-197.55
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
--
--
--
--
--
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-0.07

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
-0.07
-4.61
-3.79
-4.72
-13.84
Peer Median
--
--
--
--
--
Price / Book Value

1.04

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
1.04
4.87
4.34
2.76
3.14
Peer Median
--
--
--
--
--
EV/EBITDA

0.02

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-22
Dec-21
Dec-20
Dec-19
Dec-18
Rubius Therapeutics (RUBY)
0.02
-4.06
-3.45
-3.42
-9.96
Peer Median
--
--
--
--
--
loading...
loading...